top of page
Search

Clinsights Monthly – June Edition

Welcome to the June edition of Clinsights Monthly, where we spotlight the trends and developments shaping the future of lab testing—especially for Physician Office Labs (POLs).


This month’s edition covers four key themes:


  • The looming threat of Medicare rate cuts and what they could mean for POL revenue streams

  • New Joint Commission survey process changes that give labs more preparation time

  • The industry-wide push to address both lab test overuse and underuse—with spending and utilization trends from the top routine tests

  • And how Clinlab.AI’s AI-powered tools (vMGR and vCLS) are helping labs improve operational efficiency, quality control, and compliance readiness



Medicare Watch: Major CLFS Rate Cuts Looming for 2026 — What POLs Need to Know


After five consecutive years of Medicare CLFS (Clinical Laboratory Fee Schedule) rate freezes, labs—including Physician Office Labs (POLs)—are facing the real possibility of substantial reimbursement reductions.


Unless Congress intervenes, Medicare rates for nearly 800 lab tests are scheduled to drop by as much as 15% starting January 1, 2026. These cuts are tied to delayed implementation of rate recalculations under the Protecting Access to Medicare Act (PAMA).


Mark Birenbaum, Executive Director of the National Independent Laboratory Association (NILA), recently emphasized the urgency:


“A lot of labs have become complacent after five straight years of Medicare CLFS rate freezes. But they need to start thinking about the potential for rate cuts next year.”


For POLs, the impact could be significant. High-volume, routine tests like TSH, lipid panels, CBCs, and Vitamin D are all on the list of affected codes. Making matters more urgent: many commercial payers benchmark their rates off Medicare, meaning the downstream financial impact could extend beyond Medicare patients.


Legislative efforts like the LAB Act (H.R. 3584) and the SALSA Act are gaining attention as potential fixes. But with no guarantees yet, now is the time for practices to assess their in-house testing strategies and engage with advocacy efforts.



Compliance Corner: Joint Commission Now Offering Advance Notice for Lab Surveys


Amid looming financial pressures, labs at least have some good news on the compliance front.


As of June 2, 2025, the Joint Commission will now provide advance notice of scheduled survey events for accredited laboratories. This update follows CMS guidance aimed at reducing administrative burden and allowing labs to better prepare for inspections.


For POLs, where lab oversight often falls on small teams, this added visibility provides critical breathing room. It gives practices time to conduct internal audits, organize documentation, and address any compliance gaps before surveyors arrive.


Bottom line: This change helps labs shift from reactive fire drills to a more proactive, planned approach to accreditation readiness.




AI in Clinical Labs: How Clinlab.AI’s Tools Are Shaping the Future of Lab Management


As the lab industry responds to both financial and compliance pressures, there’s a growing recognition that AI isn’t just for diagnostics—it’s for lab operations too.


Recent industry reports have spotlighted AI in clinical labs as a rising area of policy and practice focus. While much of the conversation centers on AI in disease detection, operational AI tools are becoming equally critical—especially for POLs managing lean in-house labs.


At Clinlab.AI, we’ve built two AI-powered tools that help labs operate smarter and more efficiently:


Virtual Manager (vMGR): Traditionally, lab managers relied on spreadsheets and intuition to manage staffing, inventory, and daily workflow. vMGR changes that—offering real-time forecasting for daily sample volumes, reagent needs, and staffing plans. The result: labs can anticipate demand, avoid bottlenecks, and prevent inventory shortages before they happen.


Virtual CLS (vCLS): Quality control used to be a retrospective exercise, with issues often discovered only after patient results had already gone out. vCLS brings always-on quality monitoring, applying Westgard and Six Sigma rules nightly across all analyzers, flagging issues in real time. It even integrates Real-Time Patient QC (RTPQC) to track population-level result trends.


For POLs, this means fewer errors, better compliance, and faster, more reliable results—without adding administrative burden.


Looking ahead: As federal agencies continue evaluating how AI is used in healthcare, Clinlab.AI remains committed to delivering responsible, clinically relevant AI tools that drive better outcomes for labs and patients alike.



Lab Utilization Trends: Striking the Balance Between Overuse and Underuse


Another key theme emerging across the lab industry is the growing focus on lab utilization management—making sure the right tests are ordered at the right time, and unnecessary testing is minimized.


With nearly 14 billion clinical lab tests performed each year in the U.S., lab testing drives roughly 70% of downstream care decisions, from prescribing medications to making referrals and hospital admissions.


But according to recent national data, there’s a dual challenge:


  • More than 30% of lab testing volume may represent avoidable overuse—tests ordered with limited clinical value

  • At the same time, critical care gaps persist, with some patients not receiving essential tests needed for chronic disease management or cancer diagnostics


For POLs, this creates both risk and opportunity.


Top 5 Routine Tests Driving Lab Spend:


  • Comprehensive Metabolic Panel (CPT 80053)

  • Lipid Panel (CPT 80061)

  • CBC with Auto Diff (CPT 85025)

  • Glycosylated Hemoglobin A1c (CPT 83036)

  • Tissue Exam by Pathologist (CPT 88305)


Notably, four of these five also rank among the most frequently performed tests across the country.


How Clinlab.AI Helps: Through real-time analytics and quality oversight, Clinlab.AI’s AI tools help POLs monitor ordering patterns, reduce unnecessary testing, and ensure essential tests aren’t missed. By giving lab managers and physicians greater visibility into utilization trends, Clinlab.AI helps strike the right balance—supporting both clinical quality and cost management.




Clinlab.AI delivers turnkey, AI-powered laboratory solutions for physician offices and specialty practices. By combining cutting-edge diagnostics, automated workflows, and proprietary AI tools, Clinlab.AI empowers providers with faster, more accurate insights to enhance clinical decision-making and drive better patient outcomes.



 
 
 

Comments

bottom of page